University of Paris-Saclay-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2014

  1. Safety and effectiveness of adalimumab in patients with rheumatoid arthritis over 5 years of therapy in a phase 3b and subsequent postmarketing observational study

    Arthritis Research and Therapy, Vol. 16, Núm. 1